nepafenac · Harrow Eye · NDA 203491
Ilevro
Earliest generic entry, as listed
31 Mar 2032
Blocked by patent: US 8921337.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8921337 | product | 31 Mar 2032 |
| US 9662398 | product | 1 Dec 2030 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 203491 · 001 · RLD | suspension/drops, ophthalmic | 0.3% | 31 Mar 2032 |